Get startedLog in
    Picture of Hangzhou Jiuyuan Genetic Biopharmaceutical logo

    2566 — Hangzhou Jiuyuan Genetic Biopharmaceutical News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapContrarian
    All News

    Brief: Hangzhou Jiuyuan Genetic Biopharmaceutical Says JY54 Injection Obtains NMPA Approval To Conduct Clinical Trials In China

    Picture of Hangzhou Jiuyuan Genetic Biopharmaceutical logoHangzhou Jiuyuan Genetic Biopharmaceutical
    28/04/2026 11:28
    April 28 (Reuters) - Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd 2566.HK:

JY54 INJECTION OBTAINS NMPA APPROVAL TO CONDUCT CLINICAL TRIALS IN CHINA

Further company coverage: 2566.HK

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Hangzhou Jiuyuan Genetic Biopharmaceutical

    See all news